{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:19:10Z","timestamp":1795040350070,"version":"4.10.2"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.cbpa.2008.02.004","type":"journal-article","created":{"date-parts":[[2008,3,15]],"date-time":"2008-03-15T11:23:48Z","timestamp":1205580228000},"page":"324-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":318,"title":["Isocyanide-based multicomponent reactions in drug discovery"],"prefix":"10.1016","volume":"12","author":[{"given":"Irini","family":"Akritopoulou-Zanze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2008.02.004_bib1","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U","article-title":"Multicomponent reactions with isocyanides","volume":"39","author":"D\u00f6mling","year":"2000","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2008.02.004_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ejoc.200390167","article-title":"Recent developments in the isonitrile-based multicomponent synthesis of heterocycles","author":"Zhu","year":"2003","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3987\/REV-07-SR(U)3","article-title":"Recent advances in the development and applications of post-Ugi transformations","volume":"73","author":"Akritopoulou-Zanze","year":"2007","journal-title":"Heterocycles"},{"key":"10.1016\/j.cbpa.2008.02.004_bib4","series-title":"Multicomponent Reactions","first-page":"33","article-title":"Post-condensation modifications of the Passerini and Ugi reactions","author":"Marcaccini","year":"2005"},{"key":"10.1016\/j.cbpa.2008.02.004_bib5","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1021\/ja953868b","article-title":"Postcondensation modifications of Ugi four-component condensation products: 1-isocyanocyclohexene as a convertible isocyanide. Mechanism of conversion, synthesis of diverse structures, and demonstration of resin capture","volume":"118","author":"Keating","year":"1996","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2008.02.004_bib6_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/cr0505728","article-title":"Recent developments in isocyanide based multicomponent reactions in applied chemistry","volume":"106","author":"D\u00f6mling","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2008.02.004_bib7","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1016\/j.bmcl.2007.04.066","article-title":"Novel anti-tuberculosis agents from MCR libraries","volume":"17","author":"D\u00f6mling","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib8","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1021\/ja00385a080","article-title":"Four-component condensation: a new versatile method for the synthesis of substituted prolyl peptides","volume":"104","author":"Nutt","year":"1982","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2008.02.004_bib9","unstructured":"Block T, Davis B, Chapman T, Schofield C: Pyrrolidine compounds. WO2006061585."},{"key":"10.1016\/j.cbpa.2008.02.004_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bioorg.2006.08.004","article-title":"The Ugi reaction in the generation of new nucleosides as potential antiviral and antileishmanial agents","volume":"35","author":"Fan","year":"2007","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib11","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1016\/j.bmcl.2004.05.063","article-title":"Application of multicomponent reactions to antimalarial drug discovery. Part 1. Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts","volume":"14","author":"Musonda","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib12","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/S0040-4020(97)00223-8","article-title":"Exploitation of the Ugi 4CC reaction: Preparation of small molecule combinatorial libraries via solid phase","volume":"53","author":"Short","year":"1997","journal-title":"Tetrahedron"},{"key":"10.1016\/j.cbpa.2008.02.004_bib13","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1016\/j.bmc.2006.04.035","article-title":"Application of multicomponent reactions to antimalarial drug discovery. Part 2. New antiplasmodial and antitrypanosomal 4-aminoquinoline \u03b3-and \u03b4-lactams via a \u2018catch and release\u2019 protocol","volume":"14","author":"Musonda","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib14","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/S0040-4039(98)00653-4","article-title":"Parallel synthesis of 3-aminoimidazo [1,2-a]pyridines and pyrazines by a new three component condensation","volume":"39","author":"Blackburn","year":"1998","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-1998-1721","article-title":"Synthesis of imidazo[1,2-a]annulated pyridines, pyrazines and pyrimidines by a novel three-component condensation","author":"Groebke","year":"1998","journal-title":"Synlett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib16","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R","article-title":"A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles","volume":"37","author":"Bienaym\u00e9","year":"1998","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2008.02.004_bib17","unstructured":"Kesteleyn BRR, Schepens WBG: HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridine-5-ones. WO2007113290."},{"key":"10.1016\/j.cbpa.2008.02.004_bib18","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.bmcl.2004.04.026","article-title":"Novel nonpeptidic inhibitors of HIV-1 protease obtained via a new multicomponent chemistry strategy","volume":"14","author":"Yehia","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib19","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.bmcl.2005.04.020","article-title":"Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease","volume":"15","author":"Sperka","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/jo00427a012","article-title":"Base-induced cycloaddition of sulfonylmethyl isocyanides to C,N double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides","volume":"42","author":"Van Leusen","year":"1977","journal-title":"J Org Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3998\/ark.5550190.0008.c08","article-title":"Parallel synthesis of arrays of 1,4,5-trisubstituted 1-(4-piperidyl)-imidazoles by IMCR: a novel class of aspartyl protease inhibitors","volume":"12","author":"D\u00f6mling","year":"2007","journal-title":"ARKIVOC"},{"key":"10.1016\/j.cbpa.2008.02.004_bib22","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1016\/j.bmcl.2006.08.129","article-title":"Adamantane 11-\u03b2-HSD-1 inhibitors: application of an isocyanide multicomponent reaction","volume":"16","author":"Sorensen","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib23","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/jo01044a006","article-title":"Reactions of cyclohexylisonitrile and isobutyraldehyde with various nucleophiles and catalysts","volume":"28","author":"McFarland","year":"1963","journal-title":"J Org Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib24","unstructured":"Coburn CA, Egbertson MS, Graham SL, McGaughey GB, Stauffer SR, Rajapakse HA, Nantermet PG, Stachel SR, Yang W, Lu W, Fahr B: Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease. WO2007011833."},{"key":"10.1016\/j.cbpa.2008.02.004_bib25","unstructured":"Weyermann P, von Sprecher A, Henneb\u00f6hle M, Herzner H, Lescop C, Siendt H: Alpha-keto carbonyl calpain inhibitors. WO2006021413."},{"key":"10.1016\/j.cbpa.2008.02.004_bib26","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1021\/ol701446y","article-title":"New entry to convertible isocyanides for the Ugi reaction and its application to the stereocontrolled formal total synthesis of the proteasome inhibitor Omuralide","volume":"9","author":"Giley","year":"2007","journal-title":"Org Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib27","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1021\/jm060051s","article-title":"Design, synthesis and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists","volume":"49","author":"Habashita","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib28_1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0040-4039(97)10795-X","article-title":"The solution phase synthesis of diketopiperazine libraries via the Ugi reaction: novel application of Armstrong's convertible isonitrile","volume":"39","author":"Hulme","year":"1998","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bmcl.2006.10.084","article-title":"Spirodiketopiperazine-based CCR5 antagonists: lead optimization from biologically active metabolite","volume":"17","author":"Nishizawa","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib30","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1128\/JVI.78.16.8654-8662.2004","article-title":"Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine\/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro","volume":"78","author":"Maeda","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.cbpa.2008.02.004_bib31","first-page":"145","article-title":"CCR5 antagonists: from discovery to clinical efficacy","volume":"2","author":"Pulley","year":"2007","journal-title":"Chemokine Biol"},{"key":"10.1016\/j.cbpa.2008.02.004_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.aids.0000216362.59657.96","article-title":"GlaxoSmithKline ends aplaviroc trials","volume":"20","author":"Crabb","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.cbpa.2008.02.004_bib33","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1016\/S0040-4020(97)00218-4","article-title":"A simple procedure for the solid phase synthesis of diketopiperazine and diketomorpholine derivatives","volume":"53","author":"Szardenings","year":"1997","journal-title":"Tetrahedron"},{"key":"10.1016\/j.cbpa.2008.02.004_bib34","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.bmcl.2005.03.045","article-title":"2,5-Diketopiperazines as potent and selective oxytocin antagonists. 1. Identification, stereochemistry and initial SAR","volume":"15","author":"Wyatt","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib35","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1021\/jm050557v","article-title":"2,5-Diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality and pharmacokinetics","volume":"48","author":"Borthwick","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib36","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1021\/jm060073e","article-title":"2,5-Diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency","volume":"49","author":"Borthwick","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib37_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bmcl.2007.11.008","article-title":"The discovery of GSK221149A: a potent and selective oxytocin antagonist","volume":"18","author":"Liddle","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib38","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.bmc.2006.01.027","article-title":"Synthesis and biological evaluation of (2S)-and (2R)-2-(3\u2032-phosphonobicyclo[1.1.1]pentyl)glycines as novel group III selective metabotropic glutamate receptor ligands","volume":"14","author":"Filosa","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.cbpa.2008.02.004_bib39","unstructured":"K\u00fchnert S, Zemolka S, Haurand M, Schiene K: Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs. WO2007104485."},{"key":"10.1016\/j.cbpa.2008.02.004_bib40","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.bmcl.2005.11.102","article-title":"Design and modular parallel synthesis of a MCR derived \u03b1-helix mimetic protein-protein interaction inhibitor scaffold","volume":"16","author":"Antuch","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/anie.199601731","article-title":"Synthesis of chiral 1,1\u2032-iminodicarboxylic acid derivatives from \u03b1-amino acids, aldehydes, isocyanides, and alcohols by the diastereoselective five-center-four-component reaction","volume":"35","author":"Demharter","year":"1996","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2008.02.004_bib42","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/ol016716w","article-title":"An efficient synthesis of morpholin-2-one derivatives using glycolaldehyde dimer by the Ugi multicomponent reaction","volume":"3","author":"Kim","year":"2001","journal-title":"Org Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib43_1","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1016\/j.bmcl.2006.05.031","article-title":"Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers","volume":"16","author":"Ku","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2008.02.004_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bmcl.2006.10.040","article-title":"Towards erythropoietin mimicking small molecules","volume":"17","author":"D\u00f6mling","year":"2007","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136759310800029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136759310800029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:21:34Z","timestamp":1761272494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136759310800029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S136759310800029X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2008.02.004","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isocyanide-based multicomponent reactions in drug discovery","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2008.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}